Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
WuXi Biologics and Amicus Sign Exclusive Manufacturing Partnership 2019-02-12 08:04
WuXi Biologics and AC Immune to Establish an Exclusive Strategic Partnership 2018-12-19 20:16
WuXi Biologics Congratulates Tychan on First-in-Class Monoclonal Antibody for Yellow Fever after Record 7 Months of Development 2018-12-13 07:30
WuXi Biologics Achieves Breakthrough Titer of 51g/L in Cell Culture Productivity 2018-12-12 08:08
Oxford BioTherapeutics Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody™ Platform for Five Bispecific Antibody Programs for up to $450 Million 2018-12-11 15:00
Oxford BioTherapeutics Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody™ Platform for Five Bispecific Antibody Programs for up to $450 Million 2018-12-11 09:47
WuXi Biologics Announced Exclusive Discovery Research with Brii Biosciences for Novel Bispecific Antibody Immunotherapeutics 2018-12-10 10:21
WuXi Biologics Wins SCRIP Award for "Best Company in an Emerging Market" 2018-12-06 18:20
WuXi Biologics Wins SCRIP Award for "Best Company in an Emerging Market" 2018-12-06 18:12
WuXi Biologics Commenced Construction of the Largest Biomanufacturing Facility Using Single-Use Bioreactors in Ireland 2018-12-05 23:29
WuXi Biologics Selected as Forbes Asia's Best Under A Billion 2018 2018-11-29 21:28
WuXi Biologics and ABL Bio Enter an Exclusive Development and Clinical Manufacturing Partnership for Multiple Bispecific Antibodies 2018-11-28 19:44
WuXi Biologics Commenced Construction of 1.6 million sq. ft. Biologics Innovation Center in Shanghai 2018-11-22 14:31
WuXi Biologics' Chief Executive Officer Dr. Chris Chen to Serve on Board of Directors at ISPE and Delivered Keynote Speech at 2018 Annual Meeting 2018-11-07 17:51
WuXi Biologics Commenced Construction of 48,000L Biologics Commercial Manufacturing Center in Shijiazhuang 2018-10-31 16:08
WuXi Biologics Congratulates Tychan on Completing Human Safety Studies for the First-in-Class Zika Virus Antibody in Record Speed 2018-10-29 20:10
CANbridge Pharmaceutical and WuXi Biologics Enter into Strategic Partnership for Rare Disease Therapeutics 2018-10-23 20:00
I-Mab Biopharma Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody(TM) Platform for Three Bispecific Antibody Programs 2018-09-26 19:24
WuXi Biologics Appoints Harvard Professor David R. Liu to Scientific Advisory Board 2018-09-25 08:00
WuXi Biologics Appoints Harvard Professor David R. Liu to Scientific Advisory Board 2018-09-25 08:00
1 5 6 7 8 9